Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 276

    1.

    Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations.

    Smerhovsky Z, Landa K, Rössner P, Brabec M, Zudova Z, Hola N, Pokorna Z, Mareckova J, Hurychova D.

    Environ Health Perspect. 2001 Jan;109(1):41-5.PMID: 11171523 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations.

    Smerhovsky Z, Landa K, Rössner P, Juzova D, Brabec M, Zudova Z, Hola N, Zarska H, Nevsimalova E.

    Mutat Res. 2002 Feb 15;514(1-2):165-76.PMID: 11815255 [PubMed - indexed for MEDLINE]Related articles

    3.

    Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.

    Fucić A, Znaor A, Strnad M, van der Hel O, Aleksandrov A, Miskov S, Grah J, Sedlar M, Jazbec AM, Ceppi M, Vermeulen R, Boffetta P, Norppa H, Bonassi S.

    Toxicol Lett. 2007 Jul 30;172(1-2):4-11. Epub 2007 May 25.PMID: 17651925 [PubMed - indexed for MEDLINE]Related articles

    4.

    Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health.

    Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H.

    Cancer Res. 2000 Mar 15;60(6):1619-25.PMID: 10749131 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe.

    Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, Lazutka J, Cebulska-Wasilewska A, Puskailerova D, Znaor A, Kelecsenyi Z, Kurtinaitis J, Rachtan J, Forni A, Vermeulen R, Bonassi S.

    Am J Epidemiol. 2007 Jan 1;165(1):36-43. Epub 2006 Oct 27.PMID: 17071846 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Biomarkers of cytogenetic damage in humans and risk of cancer. The European Study Group on Cytogenetic Biomarkers and Health (ESCH)]

    Lando C, Hagmar L, Bonassi S.

    Med Lav. 1998 Mar-Apr;89(2):124-31. Italian. PMID: 9673102 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer.

    Rossner P, Boffetta P, Ceppi M, Bonassi S, Smerhovsky Z, Landa K, Juzova D, Srám RJ.

    Environ Health Perspect. 2005 May;113(5):517-20.PMID: 15866756 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries.

    Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fucic A, Gundy S, Hansteen IL, Knudsen LE, Lazutka J, Rossner P, Sram RJ, Boffetta P.

    Carcinogenesis. 2008 Jun;29(6):1178-83. Epub 2008 Mar 19.PMID: 18356148 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).

    Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen LE, Norppa H, Reuterwall C.

    Cancer Res. 1998 Sep 15;58(18):4117-21.PMID: 9751622 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A combined analysis of North American case-control studies of residential radon and lung cancer.

    Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Létourneau EG, Lynch CF, Lyon JL, Sandler DP, Schoenberg JB, Steck DJ, Stolwijk JA, Weinberg C, Wilcox HB.

    J Toxicol Environ Health A. 2006 Apr;69(7):533-97.PMID: 16608828 [PubMed - indexed for MEDLINE]Related articles

    11.

    Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective.

    Bonassi S, Znaor A, Norppa H, Hagmar L.

    Cytogenet Genome Res. 2004;104(1-4):376-82. Review.PMID: 15162068 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cytogenetic surveillance of workers exposed to genotoxic chemicals: preliminary experiences from a prospective cancer study in a cytogenetic cohort.

    Sorsa M, Ojajärvi A, Salomaa S.

    Teratog Carcinog Mutagen. 1990;10(3):215-21. Review.PMID: 1975125 [PubMed - indexed for MEDLINE]Related articles

    13.

    Micronuclei in peripheral blood lymphocytes as a possible cancer risk biomarker: a cohort study of occupationally exposed workers in Croatia.

    Znaor A, Fucić A, Strnad M, Barković D, Skara M, Hozo I.

    Croat Med J. 2003 Aug;44(4):441-6.PMID: 12950148 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cytogenetic monitoring of human populations at risk in Egypt: role of cytogenetic data in cancer risk assessment.

    Anwar WA.

    Environ Health Perspect. 1991 Dec;96:91-5. Review.PMID: 1820285 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.

    Hagmar L, Strömberg U, Tinnerberg H, Mikoczy Z.

    IARC Sci Publ. 2004;(157):207-15. Review.PMID: 15055297 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage.

    Hagmar L, Brøgger A, Hansteen IL, Heim S, Högstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, et al.

    Cancer Res. 1994 Jun 1;54(11):2919-22.PMID: 8187078 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health.

    Hagmar L, Bonassi S, Strömberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud AH, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brogger A, Forni A, Högstedt B, Lambert B, Mitelman F, Nordenson I, Salomaa S, Skerfving S.

    Mutat Res. 1998 Sep 20;405(2):171-8.PMID: 9748557 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.

    Ghosh P, Banerjee M, De Chaudhuri S, Das JK, Sarma N, Basu A, Giri AK.

    Mutat Res. 2007 Aug 15;632(1-2):104-10. Epub 2007 May 18.PMID: 17600756 [PubMed - indexed for MEDLINE]Related articles

    19.

    Genetic, cytogenetic, and carcinogenic effects of radon: a review.

    Jostes RF.

    Mutat Res. 1996 Jun;340(2-3):125-39. Review.PMID: 8692177 [PubMed - indexed for MEDLINE]Related articles

    20.

    Environmental exposure to carcinogenic polycyclic aromatic hydrocarbons--the interpretation of cytogenetic analysis by FISH.

    Sram RJ, Beskid O, Rössnerova A, Rössner P, Lnenickova Z, Milcova A, Solansky I, Binkova B.

    Toxicol Lett. 2007 Jul 30;172(1-2):12-20. Epub 2007 May 25.PMID: 17604575 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data